v3.26.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
At-the-market Offering
Common Stock
Common Stock
At-the-market Offering
Additional Paid-In Capital
Additional Paid-In Capital
At-the-market Offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 1,059,147   $ 9   $ 1,681,167   $ 812 $ (622,841)
Beginning balance, shares at Dec. 31, 2024     86,503,509          
Issuance of common stock, net of issuance cost   $ 25,022       $ 25,022    
Issuance of common stock, net of issuance costs, shares       984,000        
Issuance of common stock upon exercise of stock options 1,134       1,134      
Issuance of common stock upon exercise of stock options, shares     77,743          
Stock-based compensation 10,237       10,237      
Other comprehensive income (loss) 773           773  
Net Income (Loss) (72,178)             (72,178)
Ending balance at Mar. 31, 2025 1,024,135   $ 9   1,717,560   1,585 (695,019)
Ending balance, shares at Mar. 31, 2025     87,565,252          
Beginning balance at Dec. 31, 2024 1,059,147   $ 9   1,681,167   812 (622,841)
Beginning balance, shares at Dec. 31, 2024     86,503,509          
Ending balance at Dec. 31, 2025 1,022,934   $ 9   1,757,197   2,267 (736,539)
Ending balance, shares at Dec. 31, 2025     87,796,561          
Issuance of common stock, net of issuance cost   $ (98)   $ 0   $ (98)    
Issuance of common stock upon exercise of stock options 1,195       1,195      
Issuance of common stock upon exercise of stock options, shares     59,593          
Stock-based compensation 14,536       14,536      
Other comprehensive income (loss) (2,761)           (2,761)  
Net Income (Loss) (98,539)             (98,539)
Ending balance at Mar. 31, 2026 $ 937,267   $ 9   $ 1,772,830   $ (494) $ (835,078)
Ending balance, shares at Mar. 31, 2026     87,856,154